G. Pajkos

发表

Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.

J. Sándor, Á. Németh, I. Ember, 2004, Anticancer research.

Heterogeneity of pT3 Colorectal Carcinomas According to the Depth of Invasion

G. Cserni, R. Bori, M. Svébis, 2009, Pathology & Oncology Research.

The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.

J. Sándor, I. Ember, I. Kiss, 2000, Anticancer research.

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Young Hak Kim, N. Reinmuth, A. Chiang, 2019, The Lancet.

Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study

E. Hitre, Z. Horváth, J. Erfán, 2017, Pathology & Oncology Research.

Effects of isoflurane on Nfκb p65, Gadd45a and Jnk1 expression in the vital organs of CBA/CA mice.

J. Iványi, Balázs Kádár, I. Ember, 2011, In vivo.

Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.

K. Harrington, É. Remenár, M. Forster, 2019, European Journal of Cancer.

Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes.

J. Sándor, I. Ember, I. Kiss, 2000, Anticancer research.

Randomized phase 2 trial of a novel clonidine mucoadhesive buccal tablet for the amelioration of oral mucositis in patients treated with concomitant chemo-radiotherapy for head and neck cancer.

A. Mazar, R. Kortmann, S. Sonis, 2020, International journal of radiation oncology, biology, physics.

[Impact of microRNAs on molecular epidemiology].

K. Juhász, I. Ember, K. Gombos, 2011, Orvosi hetilap.

Personalized First-Line Treatment of Metastatic Pancreatic Neuroendocrine Carcinoma Facilitated by Liquid Biopsy and Computational Decision Support

Agnes Varga, R. Dóczi, I. Peták, 2021, Diagnostics.

Preliminary efficacy of durvalumab plus tremelimumab in platinum-refractory/resistant ED-SCLC from arm A of the phase II BALTIC study.

N. Reinmuth, I. Bondarenko, I. Vynnychenko, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer

M. Buyse, A. Piga, C. Köhne, 2001, British Journal of Cancer.

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.

M. Berger, P. Zatloukal, C. Langer, 2014, Lung cancer.

miRNA expression profiles of oral squamous cell carcinomas.

K. Juhász, I. Ember, L. Olasz, 2013, Anticancer research.

[Pharmaceutical therapy of breast cancer].

T. Pintér, I. Láng, Z. Horváth, 2010, Magyar Onkológia.

A randomized phase II study of carboplatin (C) and etoposide (E) with or without pan-BCL-2 antagonist obatoclax (Ob) in extensive-stage small cell lung cancer (ES-SCLC).

A. Szczesna, P. Zatloukal, A. Każarnowicz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.